IMO this is not a change of course. I know it sounds absurd

New Post Public Reply Private Reply Replies (1) Message Board
danwayu2 CW #54096
IMO this is not a change of course. I know it sounds absurd but the timing of the cross examinations came sooner than CEN needs it to happen. They need to resolve the site specific rezoning application at the OMB in Toronto first.. It's a chronological necessity... So it's not a change of course at all. Instead it's a necessary step to resolve that first before going through cross examinations. It's all good. Then you can go back to the JR and HC has zilcho.. Nothing, nada. Everything settles.

Creative Edge Nutrition Inc. (FITX) Stock Research Links

FITX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

How Neo Pepe Coin is Capturing Investor Attention with Presale Growth

Updated Category News Views 165

Neo Pepe Coin: Breaking Ground in the Cryptocurrency World Neo Pepe Coin ($NEOP), an emergent player in the cryptocurrency landscape, has been making waves as it progresses through multiple presale stages. This new digital currency is not only attracting crypto enthusiasts but also garnering interest from larger investors or 'whales' looking for promising opportunities. A...

Continue Reading
Upcoming Conference Call for Bio-Techne's Q1 2025 Insights

Updated Category News Views 70

Upcoming Conference Call for Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) has recently announced an upcoming conference call dedicated to discussing its financial results for the first quarter of fiscal year 2025. This important event is set for a morning slot to ensure that all stakeholders can participate and gain insights into the company's performance. Details of...

Continue Reading
Modella AI's PathChat DX Receives Major FDA Recognition

Updated Category News Views 373

Modella AI's PathChat DX Achieves Breakthrough Device Designation BOSTON -- Modella AI, a pioneer in generative and agentic artificial intelligence for biomedicine, is excited to announce that its advanced generative AI co-pilot, PathChat DX, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This remarkable recognition...

Continue Reading
Nicholas Wealth Unveils New Distribution Rate for FIAX ETF

Updated Category News Views 116

Nicholas Wealth Announces New Distribution Rate for FIAX ETF Nicholas Wealth, a well-respected player in the actively managed income exchange-traded funds (ETFs) space, has revealed an exciting increase in the distribution rate for the Nicholas Fixed Income Alternative ETF (FIAX) to 8.04%. This significant change underscores their dedication to delivering strong returns...

Continue Reading
Understanding Voting Rights and Capital in Investments

Updated Category News Views 191

Understanding Total Voting Rights in Investment Firms Investors often seek clarity regarding their holdings, and a key aspect of this is understanding total voting rights and share capital. Recently, significant information was disclosed by Hargreave Hale AIM VCT PLC, and it’s worth exploring what this means. Company Overview Hargreave Hale AIM VCT PLC stands out in the...

Continue Reading